Portfolio company
IgGenix Inc.
United States
Raised
Undisclosed
Latest stage
Series B
Rounds recorded
1 · 1 undisclosed
Backed by
4 investors
Sectors
Deep TechConsumer Wellbeing
About
This biotechnology company develops antibody-based therapeutics to treat food and environmental allergies for patients with life-threatening allergic reactions.
Source